AKT1 inhibitors(Atavistik Bio Inc)

N/A

Report date: 2026/01/05 09:43:07
NME

Base Information

Drug NameAKT1 inhibitors(Atavistik Bio Inc)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionSerine/threonine-protein kinase AKT1 inhibitors
TargetsSerine/threonine-protein kinase AKT1
Therapy Area/IndicationsTelangiectasia, Hereditary HemorrhagicVascular Malformations
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesAtavistik Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesAtavistik Bio Inc
Inactive CompaniesN/A
Active IndicationsTelangiectasia, Hereditary HemorrhagicVascular Malformations
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A